Mangoceuticals Inc
MGRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.15M
Close$
$-0.32
231.7% downside
Current Fair Value
231.7% downsideOvervalued by 231.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.15 Million |
|---|---|
| Enterprise Value | $5.25 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.17 |
| Beta | 1.98 |
| Outstanding Shares | 17,119,619 |
Return
| Return on Equity | -120.58% |
|---|---|
| Return on Assets | -106.57% |
| Return on Invested Capital | -95.67% |
Valuation & Multiples
| P/E Ratio | -0.2 |
|---|---|
| PEG | 0.26 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 31.99 |
| Enterprise Value to EBIT | -0.43 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.05%▲ 2.04% |
|---|---|
| Total Invested | $458,157▲ 53.94% |
| Investors Holding | 19▲ 1.00% |
ESG Score
No data